- Home
- DSGN vs VMD Comparison
DSGN vs VMD Comparison
Compare DSGN & VMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- VMD
- Stock Information
- Founded
- DSGN 2017
- VMD 2006
- Country
- DSGN United States
- VMD United States
- Employees
- DSGN N/A
- VMD N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- VMD
- Sector
- DSGN Health Care
- VMD
- Exchange
- DSGN Nasdaq
- VMD Nasdaq
- Market Cap
- DSGN 348.2M
- VMD 369.2M
- IPO Year
- DSGN 2021
- VMD N/A
- Fundamental
- Price
- DSGN $4.87
- VMD $8.31
- Analyst Decision
- DSGN Hold
- VMD
- Analyst Count
- DSGN 3
- VMD 0
- Target Price
- DSGN $7.00
- VMD N/A
- AVG Volume (30 Days)
- DSGN 220.6K
- VMD 141.9K
- Earning Date
- DSGN 03-18-2025
- VMD 03-05-2025
- Dividend Yield
- DSGN N/A
- VMD N/A
- EPS Growth
- DSGN N/A
- VMD 4.13
- EPS
- DSGN N/A
- VMD 0.25
- Revenue
- DSGN N/A
- VMD $214,301,000.00
- Revenue This Year
- DSGN N/A
- VMD $23.46
- Revenue Next Year
- DSGN N/A
- VMD $12.43
- P/E Ratio
- DSGN N/A
- VMD $33.26
- Revenue Growth
- DSGN N/A
- VMD 26.22
- 52 Week Low
- DSGN $2.25
- VMD $6.21
- 52 Week High
- DSGN $7.77
- VMD $10.44
- Technical
- Relative Strength Index (RSI)
- DSGN 42.19
- VMD 52.77
- Support Level
- DSGN $3.71
- VMD $8.00
- Resistance Level
- DSGN $6.81
- VMD $8.36
- Average True Range (ATR)
- DSGN 0.50
- VMD 0.24
- MACD
- DSGN -0.10
- VMD 0.05
- Stochastic Oscillator
- DSGN 37.42
- VMD 82.42
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.